维普中文期刊产品整合服务
230篇 您的检索式:作者名="Ringden"
    题名 作者 年代 出处 被引量
1Fetal mesenchymal stem -cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta 显示文摘Le Blanc K Gotherstrom C Ringden O 2005Transplantation2005,79,11:1
2Risk factors for chronic graft- versus- host disease after bone marrow transplantion: a retrospective single centre analysis显示文摘Carlens S Ringden O Remberger M 1998Bone Marrow Transplant1998,22,:1
3Mesenchymal stem cells for treatment of acute and chronic graft-versus-host disease, tissue toxicity and hemorrhages显示文摘Ringden O Blanc KL 2011Best Pracct Res Cl Ha2011,24,1:1
4GVHD prophylaxis made safe, easy, and inex- pensive显示文摘Ringden O 2014Blood2014,124,25:1
5Fetal mesenchymal stem cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta 显示文摘e Blanc K Gotherstrom C Ringden O 2005Transplantation2005,79,:1
6Mesenchymal stem cells for treatment of severe acute graft-versus-host disease显示文摘Ringden O Uzunel M Rasmusson I 2006Biol Blood Marrow Transplant2006,12,2:1
7Immunomodulation by mesenchymal stem cells and clinical experience显示文摘LE BLANC K RINGDEN O 2007Intern Med2007,262,5:1
8Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation : long-term results of a randomized trial in allogeneic marrow recipients with leukemia 显示文摘Ringden O Remberger M Ruutu T 1999Blood1999,93,:1
9Immunomodulation by mesenchymal stem cells and clinical experience显示文摘Le Blanc K Ringden O 0,,05:1
10Immunological properties of human fetal mesenchymal stem cells显示文摘Gotherstrom C Ringden O Tammik C 2004Am J Obstet Gynecol2004,190,1:1
11Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease 显示文摘Ringden O Uzunel M Rasmusson I 2006Transplantation2006,81,10:1
12Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon显示文摘Ringden O Uzunel M Sundberg B 2007Leukemia2007,21,11:1
13Rist factors for moderate-tosevere acute graft-vs-host disease after allogeneic stem allogeneic stem cell transplantation in children显示文摘Svennilson J Remberger M Ringden O 2003Pediatr transplant2003,7,2:1
14Mesenchymal stem cells inhibit the formation of cytotoxic lymphocytes (CTL), but not activated CTL or natural killer (NK) cells 显示文摘Rasmusson I Ringden O Sundberg B 2003Transplantation2003,76,:1
15Mesenchymal stem cells for treatment of acute and chronic graft-versus-host disease, tissue toxicity and hemorrhages显示文摘Ringden O Le Blanc K 2011Best Pract Res Clin Haematol2011,24,1:1
16Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms显示文摘Rasmusson I Ringden O Sundberg B 0,,:1
17Pharmacokinetics of liposomal busulphan in man显示文摘HASSAN Z LJUNGMAN P RINGDEN O 2001Bone Marrow Transplant2001,27,5:1
18Prenatal T-cell reconstitution after in utero transplantation with fetal liver cells in a patient with X-linked severe combined immunodeficiency 显示文摘Westgren M Ringden O Bartmann P 2002Arn J Obstet Gynecol2002,187,2:1
19Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastie leukemia显示文摘Ringden O Labopin M Bacigalupo A 2002J Clin Oneol2002,20,24:1
20Mesenehymal stem cells for treatment of therapy-resistant graft-versus-host disease显示文摘Ringden O Uzunel M Rasmusson I 2006Transplantation2006,81,10:1
返回顶部 每页显示:
共12页 首页 上一页 第1页 下一页 末页 /12 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费